发明授权
- 专利标题: Diketo substituted pyrrolo[2,3-c] pyridines
- 专利标题(中): 二酮取代的吡咯并[2,3-c]吡啶
-
申请号: US12490714申请日: 2009-06-24
-
公开(公告)号: US07960406B2公开(公告)日: 2011-06-14
- 发明人: Tao Wang , Yasutsugu Ueda , Lawrence G. Hamann , Zhongxing Zhang , Zhiwei Yin , Alicia Regueiro-Ren , David J. Carini , Jacob Swidorski , Zheng Liu , Barry L. Johnson , Nicholas A. Meanwell , John F. Kadow
- 申请人: Tao Wang , Yasutsugu Ueda , Lawrence G. Hamann , Zhongxing Zhang , Zhiwei Yin , Alicia Regueiro-Ren , David J. Carini , Jacob Swidorski , Zheng Liu , Barry L. Johnson , Nicholas A. Meanwell , John F. Kadow
- 申请人地址: US NJ Princeton
- 专利权人: Bristol-Myers Squibb Company
- 当前专利权人: Bristol-Myers Squibb Company
- 当前专利权人地址: US NJ Princeton
- 代理商 John F. Levis
- 主分类号: A61K31/44
- IPC分类号: A61K31/44
摘要:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketo fused azolopiperidine and azolopiperazine derivatives of Formula I: that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.